“ASH 2016 Updates: Multiple Myeloma”

Friday, February 17^th, 2017

Walker Auditorium

12:30 p.m. – 1:30 p.m.

Lunch available on a first come, first served basis

Presented by:

Dr. Sikander Ailawadhi

Vice Chair, Hematology/Oncology

Senior Associate Consultant

Mayo Clinic Florida

Learning Objectives:

Upon conclusion of this program, participants should be able to:

• Discuss updated clinical trial data from ASH 2016 annual meeting
  • Newly diagnosed multiple myeloma
  • Relapsed multiple myeloma:
    • Updated data on FDA-approved agents
    • Newer agents

“Speaker, Doctor Sikander Ailawadhi, has noted financial relationship with Abbvie, Karyophar. He intends to discuss off-label/ investigational use of a commercial product device. Course Director, Doctor James Foran, has no financial relationships to disclose or intentions to discuss off-label/ investigational use of a commercial product device.”

Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. College of Medicine, Mayo Clinic designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.  Physicians should only claim credit commensurate with the extent of their participation in the activity. Please direct all inquiries for non-physician CEU’s to Clinical Education at (3-0326) 

Credit is available to Mayo Clinic staff only.